Interestingly, CAV2 was expressed on the protein level within SMCs of ITA grafts in 7 study participants from the double-vessel CAD group (1.9%) (Fig. 6b) and 22 patients from the triple-vessel CAD group (2.3%) (Fig. 7b). The gene discussed is CAV2; the disease is coronary artery disorder.